Technology
Australian biotech, EnGeneIC, develops world-first nanocellular anti-COVID-19 vaccine that defeats mutant viruses and – GlobeNewswire
Works against mutant strains including DeltaNo need for refrigeration during transport and storage No added stabilisers or chemicals…
- Works against mutant strains including Delta
- No need for refrigeration during transport and storage
- No added stabilisers or chemicals
- Safety and immune response clinical trial recruiting now in Melbourne
- Efficacy trial planned for USA
SYDNEY and NEW YORK,…
Continue Reading
-
General14 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
Business17 hours agoWhy this ASX 200 tech stock could rise 20%
-
Business19 hours ago3 of the best ASX ETFs for beginners to buy with $1,000
-
General19 hours agoCone of Silence. Is secret Aussie spy in Rex Patrick case a man or a woman?